Paden brings to this position over 20 years of diverse experience in clinical research, including operational and scientific leadership roles, clinical trial management and monitoring, publication planning, product lifecycle management, and clinical training and education.
At Prometrika, Paden will lead clinical operations in day-to-day trial management activities and in the development of systems and procedures to further enhance the company's delivery of clinical research.
Paden's leadership roles have included head of clinical development operations at ContraFect Corp., senior consultant at Halloran Consulting, and director of clinical development medical affairs at Boehringer Ingelheim Pharmaceuticals.
Her work has covered orphan indications in oncology, cardiovascular disease, and genetic disorders.
Founded in 2003 and based in Cambridge, Massachusetts, Prometrika utilises a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team involved in all phases of trials.
Prometrika's services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers